ArticleDiabetology international2025
Long-term efficacy and safety of early sitagliptin initiation in individuals with type 2 diabetes: an extension of the SPIKE study.
Tomoya Mita et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.